Skip to main content
Log in

Fulminant hepatitis during treatment with Rifampicin, pyrazinamid and ethambutol

  • Short Communications
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

A 10-year-old girl with cervical tuberculosis was treated with Isoniazid, Rimfampicin and Ethambutol. After 2 weeks of treatment a hepatotoxic reaction developed. Withdrawal of therapy resulted in complete clinical improvement and in normalization of all laboratory measurements. Treatment was restarted with Rifampicin, Pyrazinamid and Ethambutol. Liver enzyme levels were monitored weekly. Seven weeks after this three-drug regiment was started, all therapy was discontinued because of elevated liver enzyme levels. However, the patient died 2 weeks later of progressive fulminant hepatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

TBC:

tuberculosis

INH:

isoniazid

RIF:

Rifampicin

EMB:

Ethambutol

GOT:

glutamic oxaloacetic transaminase

GPT:

gammaglutamyl transpeptidase

References

  1. Byrd CRB, Horn BR, Solomon DA, Griggs GA (1979) Toxic effects of Isoniazid in tuberculous chemo profylaxis. JAMA 241:1239–1241

    Google Scholar 

  2. Casteels-Van Daele M, Igodt-Ameye L, Corbeel L, Eeckels R (1975) Hepatotoxicity of Rifampicin ands Isoniazid in children. J Pediatr 86:739–741

    Google Scholar 

  3. Grönhagen-Riska C, Hellström PE, Fröseth B (1978) Predisposing factors in hepatitis induced by Isoniazid-Rifampin treatment of tuberculosis. Am Rev Respir Dis 118:461–466

    Google Scholar 

  4. Grosset J, Lenventis S (1983) Adverse effects of Rifampin. Rev Infect Dis 5 [Suppl]: 5440–5446

    Google Scholar 

  5. Kendig EL (1983) Tuberculosis. In: Kendig EL, Chernick V (eds) Disorders of the respiratory tract in children, 4th edn. Saunders, Philadelphia, pp 662–702

    Google Scholar 

  6. Lesobre R, Ruffino J, Teyssier L, Achard F, Brefort G (1969) Les ictères au course du traitment par la rifampicin. Rev Tuberc Pneumol 33:393–403

    Google Scholar 

  7. Mitchell JR, Potter WZ, Hinson JA, Snodgrass WR, Timbrell JA, Gillette JR (1975) Toxic drug reactions. In: Gillette JR, Mitchell JR (eds) Handbook of experimental pharmacology. Springer, New York, pp 382–419

    Google Scholar 

  8. Nebout T, Dhumeaux D, Berthelot P (1974) Ictères et Rifampicine. Nouv Presse Med 3:733–736

    Google Scholar 

  9. Smith J, Tyrell WF, Gow A, Allan GB, Lees AW (1972) Hepatotoxicity in Rifampin-Isoniazid treated patients related to their rate of Isoniazid inactivation. Chest 61:587–588

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Aalderen, W.M.C., Knoester, H. & Knol, K. Fulminant hepatitis during treatment with Rifampicin, pyrazinamid and ethambutol. Eur J Pediatr 146, 290–291 (1987). https://doi.org/10.1007/BF00716476

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00716476

Key words

Navigation